packageMarstacimab

marstacimab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Marstacimab, a monoclonal antibody, is used to treat hemophilia A and hemophilia B. It is authorised in the European Union as a systemic hemostatic medicine.

Summary written by glm-5.3-flash from Wikidata Q130351881 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:marstacimab
ATC codes:B02BX11
DrugBank:DB17725
Wikidata:Q130351881

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown